Dr. Boru Jin | Neuroscience | Best Researcher Award
Dr. Boru Jin | Neuroscience | lecturer | First hospital of China medical university | China
Dr. Boru Jin is an accomplished female neurologist and lecturer who has established herself as a promising researcher in the field of neurodegenerative disorders. Currently serving as a lecturer and attending physician at the China Medical University Affiliated First Hospital, she combines clinical excellence with scientific rigor, contributing to innovative approaches in diagnosis, prevention, and treatment of cognitive and neuropsychiatric conditions. Her research integrates advanced bioinformatics and clinical data analysis to uncover biomarkers for early detection of neurodegenerative diseases, thereby helping improve patient outcomes and supporting the development of precision medicine strategies. Dr. Boru Jin’s professional journey reflects dedication to both academic scholarship and clinical practice, making her a valuable contributor to neurology and neuroscience research.
Professional Profile
Education
Dr. Boru Jin has completed a comprehensive academic pathway in neurology through leading medical institutions in China. She obtained her master’s degree in neurology from China Medical University through an integrated medical program, followed by a doctoral degree in neurology from Fudan University, one of the nation’s top research universities. Her advanced training has equipped her with a robust understanding of neurological disorders, clinical research methodologies, and translational science approaches. This educational background has been instrumental in shaping her career as a clinician-scientist committed to bridging the gap between bench research and bedside application.
Experience
Dr. Boru Jin currently holds a dual role as a lecturer and attending physician, where she is actively engaged in teaching medical students, mentoring young researchers, and delivering high-quality patient care. Her experience includes participating in collaborative research projects that focus on Alzheimer’s disease, dementia, and cognitive impairment. She has contributed to multiple systematic reviews and network meta-analyses that have been published in internationally indexed journals. Her professional involvement also extends to serving as a member of several national academic committees, including divisions on Alzheimer’s disease and cognitive impairment, where she participates in shaping policies and research priorities for geriatric mental health and neurological care.
Research Interest
Dr. Boru Jin’s primary research interest lies in the study of neurodegenerative diseases, with a particular focus on Alzheimer’s disease, dementia syndromes, and vascular cognitive impairment. She applies integrated bioinformatic analyses and machine learning strategies to identify diagnostic biomarkers that differentiate among neurodegenerative conditions. Her research also explores therapeutic interventions for depressive symptoms, migraine, and behavioral manifestations of dementia using network meta-analytical approaches. She is passionate about developing evidence-based treatment strategies and improving clinical guidelines to enhance the quality of care for patients with neurological disorders.
Award
Dr. Boru Jin has been recognized for her contribution to clinical neurology and research excellence through her active participation in professional committees and scholarly output. Her role as a member of national associations dedicated to geriatric medicine and cognitive impairment highlights her leadership potential and commitment to advancing the field. These recognitions underscore her growing influence in both academic and clinical circles, positioning her as an emerging leader in neurological research.
Selected Publication
“Repopulation of Microglia and Its Implications for CNS Disorders: Insights from the Single-Cell Era” published in 2025 with 68 citations
“Identification of Diagnostic Biomarkers in Alzheimer’s Disease by Integrated Bioinformatic Analysis and Machine Learning Strategies” published in 2023 with 52 citations;
“Identification of Biomarkers Differentiating Alzheimer’s Disease from Other Neurodegenerative Diseases by Integrated Bioinformatic Analysis and Machine Learning Strategies” published in 2023 with 47 citations
“Comparative Efficacy and Acceptability of Treatments for Depressive Symptoms in Cognitive Impairment: A Systematic Review and Bayesian Network Meta-Analysis” published in 2022 with 41 citations.
Conclusion
Dr. Boru Jin exemplifies the qualities of an outstanding clinician-scientist through her integrated approach to patient care, academic teaching, and pioneering research. Her work in identifying diagnostic biomarkers and conducting large-scale meta-analyses contributes significantly to improving early diagnosis and treatment strategies for neurodegenerative diseases. Her leadership roles in professional organizations and mentorship activities further reflect her dedication to the advancement of neuroscience education and community health. With her strong foundation in research, clinical practice, and interdisciplinary collaboration, Dr. Boru Jin is exceptionally deserving of recognition in this award category and is poised to make even greater contributions to the global neurological research community in the coming years.